Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized study of cenerimod in Japanese adults with moderate to severe systemic lupus erythematosus
jRCT2011210019Phase 2Completed
- Sponsor
- Idorsia
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cenerimod in systemic lupus erythematosus (SLE) (2 arms), sponsored by Idorsia. Started Nov 2021; status: completed.
02
Drugs
cenerimod
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT2011210019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011210019.